Last reviewed · How we verify
NCT05784818
Up To Me: Erasing the Stigma of Mental Illness on College Campuses
NA trial testing Up To Me Intervention + No Booster in Mental Illness in 201 participants. Status unknown.
30 March 2024
Quick facts
| Lead sponsor | University of South Florida |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 201 |
| Start date | 7 March 2022 |
| Primary completion | 30 March 2024 |
| Estimated completion | 30 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Up To Me Intervention + No Booster
- Up To Me Intervention + Booster
Conditions studied
- Mental Illness — all drugs for Mental Illness →
- Behavior Disorders — all drugs for Behavior Disorders →
- Severe Mental Illness — all drugs for Severe Mental Illness →
- Psychiatric Diagnosis — all drugs for Psychiatric Diagnosis →
Sponsor
University of South Florida
Who can join
18 and older, any sex, with Mental Illness or Behavior Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a three-lesson, disclosure-based stigma reduction program meant to reduce barriers to community living and participation for college students with psychiatric disabilities. The goal is to improve community living and participation of individuals with psychiatric disabilities within their postsecondary community using the Honest Open Proud (HOP) program. There are 3 specific objectives of the project:1) evaluate program fidelity, 2) assess program feasibility, and 3) conduct a randomized controlled trial of the HOP program with college students with mental illness to examine its efficacy. Anticipated outcomes include increases in 1) community integration, 2)self-esteem and self-efficacy, 3) empowerment and self-determination, 4) disclosure of mental illness in order to obtain needed support, and 5) care seeking/service engagement for mental illness. Ultimately, we expect to see increased academic persistence and achievement among HOP program completers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05784818
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Illness
Currently open trials in the same condition.
- NCT07396623 — Validation of French PHQ-4 and PC-PTSD-5 Screening Scales · recruiting
- NCT05776316 — Harm Reduction Services · NA · recruiting
- NCT04881084 — Exploring Empathy and Compassion Using Digital Narratives · NA · recruiting
- NCT06290648 — Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings · NA · active not recruiting
- NCT06315114 — A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders · NA · recruiting
Other University of South Florida trials
Trials by the same sponsor.
- NCT07529366 — Pharmacist-Led Continuous Glucose Monitoring for Prediabetes · recruiting
- NCT07342569 — The WeACT Program for Family Caregivers of People Living With Dementia · NA · not yet recruiting
- NCT07502378 — Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic · Phase 4 · recruiting
- NCT07241260 — Hydrate Heroes for Improving Brain Function & Mood · NA · not yet recruiting
- NCT06377215 — Understanding Aided Speech Perception in Noise · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05784818 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Florida
- Last refreshed: 27 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05784818.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing